Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Lawmaker Asks FDA To Launch Criminal Inquiry Into Power Morcellators

This article was originally published in The Gray Sheet

Executive Summary

Rep. Mike Fitzpatrick, R-Pa., is asking FDA's criminal office to investigate whether Ethicon and several East Coast hospitals fulfilled safety reporting requirements for power morcellators, which have been linked to a risk of spreading cancer in women undergoing treatment for uterine fibroids.

Advertisement

Related Content

Lawmakers Plan Bill In Response To GAO Power Morcellator Report
'Cures' Bill Passes, As More Budget, Safety Debates Wait In The Wings

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register